Brief: Lineage Cell Therapeutics Announces Extension Of Opregen Development Grant From Israel Innovation Authority
06/07/2020 13:08
July 6 (Reuters) - Lineage Cell Therapeutics Inc LCTX.A :
* LINEAGE CELL THERAPEUTICS ANNOUNCES EXTENSION OF OPREGEN
DEVELOPMENT GRANT FROM ISRAEL INNOVATION AUTHORITY
Source text for Eikon: ID:nBw7344nsa
Further company coverage: LCTX.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million